Making a Difference – Innovations in Infection Prevention 2020
C Diff Foundation acknowledges the following organizations “Making a Difference”
In the Infection Prevention community, with their innovative products, services, and
technologies addressing infection prevention.
Innovation: SilvaClean® Technology
SilvaClean chemistry is EPA-approved as a laundry additive with residual activity
against post-laundry contamination.
The SilvaClean system is a dispensing device enabled by the Internet of Things (IoT)
that doses the EPA-approved SilvaClean chemistry onto textiles, leaving fabrics with
residual antimicrobial properties even after laundering (e.g. in storage, during handling
and in use).
Innovation: UVC Dosimeter™
Able to measure specific wavelengths of UVC radiation.
Can be correlated with a log reduction of microbiology samples e.g. MRSA and C. diff.
Proven functionality through hospital testing.
Synexis Biodefense Systems
Innovation: Synexis™ Microorganism Reduction Systems
Patented Dry Hydrogen Peroxide (DHP) technology uses a building’s ambient humidity
and oxygen to continuously achieve sustainable reduction of microbial challenges from
viruses, bacteria, and mold in the air and on workplace surfaces.
DHP technology is inexpensive, highly scalable, and can be installed standalone or in
existing HVAC systems.
Join Us in November!
Join Us at the 8th Annual International C. diff. Conference and Health EXPO taking
place in Boston, Massachusetts USA on November 12th and 13th, 2020 where we will
present and showcase these prestigious awards to the 2020 “Making a Difference” Innovations In Infection Prevention organizations.
Early Bird Registration is in progress — save over 20% until June 2020.
Congratulations to the organizations dedicated in preventing infections and for
developing products, services, and technology capable to ward off harmful bacteria in
all areas of health care and commercial environments. We are truly grateful for the
innovative measures taken to accomplish this goal.
C Diff Foundation, a 501(c) (3) non-profit organization, established in 2012, and
comprised of 100% volunteering professionals dedicated at supporting public health
through education and advocating for C. difficile infection (CDI) prevention, treatments,
clinical trials, diagnostics, and environmental safety worldwide.
(Disclaimer: C Diff Foundation declares no conflict of interest; no funds or influence
were provided to C Diff Foundation by any parties.)